Anatomical distribution of peptic ulcer in high incidence gastric cancer area
Abstract
Background: Peptic ulcer makes reference to the solution of continuity of gastric or duodenal wall beyond muscularis mucosae. Previously, duodenal location was more common than gastric, in a ratio ranging from 2:1 to 4:1. Despite this, after the discovery of the association between peptic ulcer and Helicobacter pylori, relationship between gastric and duodenal ulcer has spread to the equality. However, in areas with high incidence of gastric cancer, peptic ulcer seems to have a different behavior, existing predominance of gastric ulcer. Department of Cauca is have the highest incidence of gastric cancer in Colombia, with an annual rate of 42.5 /100,000 for males and 28.6 / 100,000 for women; however, it is unknown how peptic ulcer anatomically are distributed. Objective: To determine the anatomical distribution of peptic ulcer at endoscopy service of San José University Hospital of Popayán-Cauca, Colombia 2006-2012. Methods: A descriptive cross-sectional study was realized. Database of endoscopy service of San José University Hospital of Popayán was reviewed and reports with diagnosis of peptic ulcer were studied. Data were analyzed using SPSS-15. Results: Gastric ulcer was more common than duodenal ulcer. Gastric ulcer was more common in men (gastric and duodenal ulcer 1:1). In women duodenal ulcer is 1:1. Conclusion: At endoscopy service of San José University Hospital, gastric ulcer is more common than duodenal ulcer, with differences in gender, as in other areas with high incidence of gastric cancer. That fact are suggests in current literature could be related with the presence of stumps of Helicobacter pylori with combined virulence for cancer and ulcer at gastric level seems to be related to the presence in the medium of common virulence strains of Helicobacter pylori for stomach cancer and ulcer gastric, although the current literature is unclear about it, and still needs more validations.Downloads
References
Chan F, Leung W. Peptic ulcer disease. Lancet. 2002 Sep; 360 (9337):933-41. Disponible en: http://www.ncbi.nlm.nih.gov. Consultado el 16 de septiembre de 2014.
Yuan X, Xie C, Chen J, Xie Y, Zhang K, Lu N. Seasonal changes in gastric mucosal factors associated with peptic ulcer bleeding. Exp Ther Med. 2015 Jan; 9 (1):125-30.
Liang C, Muo C, Wang I, Chang C, Chou C, Liu J, at al. Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcer genic effect of medications. PLoS One. 2014 Feb; 9 (2): e87952. Disponible en: http://www.ncbi.nlm.nih.gov. Consultado el 16 de septiembre de 2014.
Malfertheiner P, Chan F, McColl K. La enfermedad de úlcera péptica. Lancet. 2009 Oct 24;374(9699):1449-61. Disponible en: http://www.ncbi.nlm.nih.gov. Consultado el 16 de septiembre de 2014.
Charpignon C, Lesgourgues B, Pariente A, Nahon S, Pelaquier A,
Gatineau G, at al. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment Pharmacol Ther. 2013 Oct;38 (8):946-54.
Gisbert J, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther. 2009 Oct 15;30(8):791-815.
Yamaoka Y. Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract. 2012; 2012:371503.
Liu J, He C, Chen M, Wang Z, Xing C, Yuan Y. Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infect Dis. 2013 Nov;13 (1): 555. Disponible en: http://www.ncbi.nlm.nih.gov Consultado el 02 de octubre de 2014.
Mynatt R, Davis G, Romanelli F. Peptic ulcer disease: clinically relevant causes and treatments. Orthopedics. 2009 Feb; 32 (2):104.
Chen M, He C, Meng X, Yuan Y. Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer. World J Gastroenterol. 2013 Jul 14; 19 (26): 4242-51.
Scarpignato C, Hunt RH. Nonsteroidal anti-inflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am. 2010 Sep; 39 (3): 433-64.
Kawamura N, Ito Y, Sasaki M, Iida A, Mizuno M, Ogasawara N, at al. Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers. BMC Res Notes. 2013 Nov 12; 6:455. Disponible en: http://www.ncbi.nlm.nih.gov. Consultado el 02 de octubre de 2014.
Cryer B, Feldman M. Effects of very low dose daily, longterm aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology. 1999 Jul; 117 (1): 17-25.
Ruigómez A, Johansson S, Nagy P, Martín M, Rodríguez L. Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events. BMC Gastroenterol. 2014 Dec; 14 (1): 205.
García L, Hernández S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol. 2004 Jan 1; 159 (1): 23-31.
Bobadilla J, Vargas F, Gómez A, Villalobos J. Frecuencia de la úlcera péptica en el Instituto Nacional de la Nutrición “Salvador Zubirán”; Estudio de localización, factores asociados y tendencias temporales. Rev Gastroenterol Méx. 1996; 61 (1): 31-5.
Kurata J, Haile B. Epidemiology of peptic ulcer disease. Clin Gastroenterol. 1984 May; 13 (2): 289-307.
Bonnevie O. Changing demographics of peptic ulcer disease. Dig Dis Sci. 1985 Nov;30(11 Suppl):8S-14S. Disponible en: http://www.ncbi.nlm.nih.gov.
Ángel L, Gómez D, Villalba M. Epidemiological evolution of acid peptic disease in an Endoscopic Diagnostic Center in Bogotá from 1993 and 2007. Rev Col Gastroenterol. 2010; 25 (2): 139-153.
Llorens P, Nakamura K. Diagnóstico y tratamiento de las afecciones gástricas. 1ra Ed. VII: Úlcera Péptica. 1. Aspectos Clínicos y Epidemiológicos. Chile. Instituto Chileno- Japonés de Enfermedades Digestivas; 1995. p. 215-21.
Weitz J, Berger Z, Sabah S, Silva H. Diagnóstico y tratamiento de las enfermedades digestivas. 1ra Ed. Úlcera péptica. Chile. Sociedad Chilena de Gastroenterología; 2008. p. 126-37.
Medina E, Csendes A, Kaempffer A. Aspectos epidemiológicos de la úlcera péptica, Rev Med Chile. 1976; 96. p. 788, 1976.
Ministerio de Salud y protección social. Cáncer en cifras. Incidencia, Cauca, hombres, mujeres. [Internet]. 2013 [citado 2015 mar 31]. Disponible en: Http://www.cancer.gov.co/content/estadisticas.
Adrada J, Calambás F, Díaz J, Delgado D, Sierra C. Características sociodemográficas y clínicas en una población con cáncer gástrico en el Cauca, Colombia. Rev Col De Gastroenterología. 2008 Oct-dic; 23 (4): 309-14.
Kurata J. Ulcer epidemiology: an overview and proposed research framework. Gastroenterology. 1989 Feb; 96 (2 Pt 2 Suppl): 569-80.
González A, Sáez M, Johansson S, Nagy P, García L. Risk factors associated with uncomplicated peptic ulcer and changes in medication use after diagnosis. PLoS One. 2014 Jul 8; 9 (7): e101768. Consultado el 05 de octubre de 2014.
Aro P, Storskrubb T, Ronkainen J, Bolling E, Engstrand L, Vieth M, at al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006 Jun 1; 163 (11):1025-34.
Farhad B, Abbas Y, Farhad P, Sadaf G, Epidemiology of Peptic Ulcer Disease: Endoscopic Results of a Systematic Investigation in Iran. Am J Gastroenterol. 2012 Dec;100(13):3870-9.
Bao Y, Spiegelman D, Li R, Giovannucci E, Fuchs C, Michaud D. History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterol. 2010 Feb; 138 (2): 541-9.
Li Z, Zou D, Ma X, Chen J, Shi X, Gong Y, at al. Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol. 2010 Dec; 105 (12): 2570-7.
Hong J, Xia L, Zuo W, Wang A, Xu S, Xiong H, at al. Risk factors for intestinal metaplasia in concomitant gastric and duodenal ulcer disease. Exp Ther Med. 2014 Apr; 7 (4): 929-934.
Coggon D, Lambert P, Langman M. 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet. 1981 Jun 13; 1 (8233):1302-4.
Hansson L. Risk of stomach cancer in patients with peptic ulcer disease. World J Surg. 2000 Mar; 24 (3): 315-20.
Zhang Z, Newcomb P, Hollowood A, Moganaden, Gupta J, Feakins R, at al. A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci. 2004 Feb; 49 (2): 254-9.
Lewis JH, Woods M. Gastric carcinoma in patients with unoperated duodenal ulcer disease. Am J Gastroenterol. 1982 Jun;77(6):368-73.
Norfleet R, Johnson SE. Strange bedfellows: duodenal ulcer and cancer of the stomach. J Clin Gastroenterol. 1989 Aug; 11 (4): 382-5.
Molloy R, Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut. 1997 Feb; 40 (2): 247-52.
Lv S, Gan J, Wang C, Luo E, Huang X, Xie Y, at al. Biopsy from the base of gastric ulcer may find gastric cancer earlier. Med Hypotheses. 2011 Feb; 76 (2): 249-50.
Eidt S, Stolte M. Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol. 1994 Jul; 29 (7): 607-10.
Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo V, at al. The long term outcome of gastric non-invasive neoplasia. Gut. 2003 Aug ;52 (8): 1111-6.
Hong J, Zuo W, Wang A, Xu S, Tu L, Chen Y, at al. Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients. Oncol Lett. 2014 Dec; 8 (6): 2790-4.
Shiota S, Suzuki R, Matsuo Y, Miftahussurur M, Tran T, Binh T, at al. Helicobacter pylori from gastric cancer and duodenal ulcer show same phylogeographic origin in the Andean region in Colombia. PLoS One. 2014 Aug; 9 (8): e105392. Disponible en: http://www.ncbi.nlm.nih.gov. Consultado el 04 de mayo de 2014.
Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010 Nov; 7 (11): 629-41.
Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis. 2013 Jul; 14 (7): 341-9.
Beltrán F, Poblete T, Román A, Reyes S, de Sampedro J, Peralta O, et al. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population. BMC Gastroenterol. 2014 Dec 24; 14 (1): 223.
Matteo M, Granados G, Pérez C, Olmos M, Sanchez C, Catalano M. Helicobacter pylori cag pathogenicity island genotype diversity within the gastric niche of a single host. J Med Microbiol. 2007 May; 56 (Pt 5): 664-9.
Nomura A, Lee J, Stemmermann G, Nomura R, Perez G, Blaser M. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis. 2002 Oct 15; 186 (8):1138-44.
Siddique I, Al-Qabandi A, Al-Ali J, Alazmi W, Memon A, Mustafa A, et al. Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East. Gut Pathog. 2014 Sep; 6 (1): 41.
Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013 Jan; 7 (1): 35-40.
Acosta C, Muñoz S, Sierra H. Resúmenes VIII Congreso Colombiano de genética. Frecuencia de los genes Cag A, Ice A y Vac A en pacientes con Helicobacter pylori asociados con cáncer gástrico en el Cauca. Colomb Med. 2008; 39 (2): 66.
.png)
